AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Pharma company files FDA IND for Provectus, treatment of solid tumors.
2004 SEP 20 - (NewsRx.com & NewsRx.net) -- Provectus Pharmaceuticals, Inc., (BULLETIN BOARD: PVCT) announced that it has filed an investigational new drug (IND) application for Provecta, an advanced drug therapy designed to treat breast, liver, prostate and other potentially deadly cancers.
If the U.S. Food & Drug Administration (FDA) accepts the application, Provectus expects to begin enrolling patients in clinical trials beginning early 2005.
Provectus has completed a full range of successful preclinical studies in laboratory models. When injected into tumor tissue, Provecta concentrates in the tumor and then quickly dissipates from surrounding, healthy tissue. This characteristic makes the drug potentially safer and more effective than conventional therapies.
Related preclinical studies using Provecta as a radiosensitizer currently are underway at the University of Wisconsin-Madison. Because Provecta increases the effects of radiation on tumor tissue, substantially less radiation may be needed, thereby subjecting patients to fewer side effects. Additionally, Provecta has been used to treat a number of ...
- Provectus Pharmaceuticals' Craig Dees, Ph.D. to Speak in Joy Goodwin Lecture...
- Press release article from: PR Newswire October 15, 2004 700+ words
...Craig Dees, Ph.D., CEO of Provectus Pharmaceuticals, Inc. (BULLETIN BOARD: PVCT...focus on recent developments at Provectus Pharmaceuticals including the use of pharmacological...and his fellow scientists at Provectus Pharmaceuticals Inc. have discovered a new method...
- Rodman & Renshaw, LLC Initiates Coverage of Provectus Pharmaceuticals, Inc....
- Press release article from: Business Wire November 27, 2007 700+ words
...initiated research coverage of Provectus Pharmaceuticals, Inc. (NASDQ: PVCT - News...interest in the securities of Provectus Pharmaceuticals, Inc. (including, without...of common equity securities of Provectus Pharmaceuticals, Inc. Neither the research...
- Provectus Pharmaceuticals Gains FDA Clearance of Investigational New Drug...
- Press release article from: PR Newswire October 11, 2004 700+ words
...Patients Planned for Early 2005 Provectus Pharmaceuticals, Inc. (BULLETIN BOARD: PVCT...against tumors in humans." About Provectus Pharmaceuticals, Inc. Provectus Pharmaceuticals, Inc. (BULLETIN BOARD: PVCT...
- Provectus Pharmaceuticals, Inc. (OTCBB:PVCT) just released some important news.
- Press release article from: M2 Presswire July 7, 2008 700+ words
...July 2008-Stockwire.com: Provectus Pharmaceuticals, Inc. (OTCBB:PVCT) just...COMMUNICATIONS LTD RDATE:07072008 Provectus Pharmaceuticals, Inc. (OTCBB:PVCT) just...Treated. A dedicated Chat Room for Provectus Pharmaceuticals, Inc., has been created at...
- Provectus Pharmaceuticals, Inc. (OTCBB: PVCT) just released some important news.
- Press release article from: M2 Presswire September 10, 2008 700+ words
...2008-Stockwire.com: Provectus Pharmaceuticals, Inc. (OTCBB: PVCT...COMMUNICATIONS LTD RDATE:10092008 Provectus Pharmaceuticals, Inc. (OTCBB: PVCT) just announced Provectus Pharmaceuticals Inc. Will Present at...
- Provectus Pharmaceuticals 10Q Highlights New Financial Capability.
- Press release article from: PR Newswire August 17, 2004 700+ words
...to Continue as a Going Concern Provectus Pharmaceuticals, Inc. (BULLETIN BOARD: PVCT...yesterday in its form 10-QSB. Provectus Pharmaceuticals, Inc. licenses and sells products...credibility of our company," said Provectus Pharmaceuticals CEO Craig Dees, Ph.D. "This...
- Provectus Pharmaceuticals, Inc. Makes Comments Regarding 2006.
- Press release article from: M2 Presswire March 28, 2007 700+ words
...March 2007-Breaking News: Provectus Pharmaceuticals, Inc. Makes Comments Regarding...attention of our research team. Provectus Pharmaceuticals, Inc. (OTC BB: PVCT), is...and American exchanges offer. Provectus Pharmaceuticals, Inc. (OTCBB: PVCT) announced...
- Provectus Pharmaceuticals Completes Sale of Equity Securities.
- Press release article from: PR Newswire December 9, 2004 700+ words
Provectus Pharmaceuticals, Inc. (BULLETIN BOARD: PVCT) announced...used for general corporate purposes. About Provectus Pharmaceuticals, Inc. Provectus Pharmaceuticals, Inc. (BULLETIN BOARD: PVCT - News) is...
- Provectus Pharmaceuticals Announces Execution of $20.75 Million in Equity...
- Press release article from: PR Newswire July 28, 2004 700+ words
Provectus Pharmaceuticals, Inc. (BULLETIN BOARD...cornellcapital.com/. Provectus Pharmaceuticals Inc. licenses and sells...Craig Dees, CEO of Provectus Pharmaceuticals, Inc., +1-865...
- Provectus Pharmaceuticals Appoints Dr. Paul M. Goldfarb to Corporate Advisory...
- Press release article from: PR Newswire April 28, 2004 700+ words
Provectus Pharmaceuticals, Inc. (BULLETIN BOARD: PVCT) announced...of our pharmaceutical technologies." About Provectus Pharmaceuticals, Inc. Provectus Pharmaceuticals, Inc. is a pioneering pharmaceutical company...
Source: HighBeam Research, Pharma company files FDA IND for Provectus, treatment of solid tumors.